670 
Infertility Treatment by in vitro Fertilization or Intra-cytoplasmic Sperm Injections in Chronic HIV-1 Sero-different Couples: Do Women, HIV Infection, or Infertility Influence Results?
Roland Tubiana*, N Prisant, F Marguet, S Dominguez, M Naouri, O Rosemblum, G Lefebvre, D Vauthier, A Marcelin, C Poirot, and Pitie Salpetriere AMP a Risque Viral Study Group
Hosp Pitie-Salpetriere, Paris, France
Background: Since 2001, French law allows
the use of assisted reproductive treatment in couples in which a member is HIV
infected. Most published results concern fertile patients. Being infected does
not preclude being fertile. This study presents results of a comprehensive assisted
reproductive treatment program dealing with chronic HIV-1-infected, infertile
patients and the outcome of assisted reproductive treatment (i.e. take-home
baby rate) according to HIV carrier and gender cause of infertility .
Methods: This retrospective study, 2002 to
2006, used the following major Inclusion criteria were: CD4 lymphocyte count
>200/mm3 and a stable HIV viral load <4 months prior to
assisted reproductive treatment, and undetectable plasma viral load within 2
weeks for the negative partner. After a viral screening
of selected sperm (after washing if the male is HIV+) and a cryo-preservation
of virus-free straws, in vitro fertilization or intra-cytoplasmic sperm
injection was performed according to the etiology of infertility. Couples
without fertility problems treated with intrauterine insemination (70% in our
program) and couples with both partners infected are not included in this study.
Results: Of 75 couples, 45 HIV+
women (group A) had HIV– partners, and 30 HIV– women (group
B) had HIV+ partners. Among group A, 26 woman were unfertile and 19 had
an infertile partner. Among group B, 5 women were infertile. Of 30 HIV+
men and of 45 HIV+ women, 27 and 39, respectively, were treated with
HAART, 79% with a plasma viral load below the level of quantification at time
of enrolment. The median female CD4 level was 518/mL (179 to 1339). We achieved
a 13.1% clinical pregnancy rate per attempt, with a 17.3% take-home baby rate
per couple. We compared assisted reproductive treatment outcome between group A
and B. Median age of 34.5 years (35 to 44), rank of attempt, assisted
reproductive treatment, CD4 count, and viral load were not different. Take-home
baby rate per treated couple was 13.3% in group A vs 23.3% in group B. Within
group A we identified 2 sub-groups, either a female (n = 26) or a male (n
= 19) etiology of infertility, with 7.7 vs 21% take-home baby rate, respectively.
Among fertile women (n = 44), results were 21% and 20% of take-home baby
rate, respectively, in HIV+ and HIV– women. None of these
comparisons was significant using Fischer’s exact test.
Conclusions: We found no difference in
terms of assisted reproduction results between HIV+ and HIV–
.women in the absence of female etiology of infertility (21% vs 20%). The
lowest rate of success (7.7%) was found in couples in whom the women have both fertility
impairment and HIV infection.
|